top of page

About Us

  • Facebook
  • Twitter
  • LinkedIn

Liquid biopsy is a minimally invasive blood-based approach that has the potential of providing information on early diagnosis, prognosis, response to therapeutic regimens and chemo-resistance development. The detection and molecular characterization of circulating tumor cells (CTCs), the detection of circulating tumor DNA (ctDNA), circulating microRNAs (miRNAs) and exosomes, in the peripheral blood of cancer patients, represent the main liquid biopsy approaches.

​

The aim of the society is the study of biology and clinical significance of CTCs, circulating nucleic acids (ctDNA, circulating miRNAs) and exosomes in the peripheral blood of cancer patients, as long as their interplay with the immune system in different stages of cancer development.    

Board of Directors

Evi S. Lianidou, President

Markou Athina, Vice President

Strati Areti, Secretary-General

Kallergi Galatea, Cashier

Georgoulias Vasilis, Member

Ntzifa Aliki, Member

Stergiopoulou Dimitra, Member

 

​

Associate Members:

Koutsopoulos Anastasios

Balgkouranidou Ioanna

Find Us On
Membership applications

Membership is open to all Greek researchers and clinical oncologists that work in the field of liquid biopsy.

hslblogo.png
bottom of page